Cargando…

Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study

OBJECTIVES: Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of America 2010 C. difficile guideline. The primary objective of this study was to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbeddini, Ali, Gerochi, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877108/
https://www.ncbi.nlm.nih.gov/pubmed/33568232
http://dx.doi.org/10.1186/s40545-020-00289-1
_version_ 1783650099915653120
author Elbeddini, Ali
Gerochi, Rachel
author_facet Elbeddini, Ali
Gerochi, Rachel
author_sort Elbeddini, Ali
collection PubMed
description OBJECTIVES: Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of America 2010 C. difficile guideline. The primary objective of this study was to assess the treatment adherence to our algorithm; this was defined as therapy consisting of the appropriate antibiotic, dose, route, interval, and duration indicated based on the disease severity and episode within 24 h of diagnosis. Furthermore, our study also described the population and their risk factors for CDI at our hospital. METHODS: This was a single-centre, retrospective cohort chart review of CDI cases that were diagnosed at admission or during hospitalization from June 1st, 2017 to June 30th, 2018. Cases were identified by a positive stool test along with watery diarrhea or by colonoscopy. RESULTS: Sixty cases were included, of which adherence to our algorithm was 50%. Overall, severe CDI had the highest treatment non-adherence (83%), and the biggest contributing factor was prescribing the wrong antibiotic (72%). In severe CDI, which warrants vancomycin monotherapy, wrong antibiotic consisted of metronidazole monotherapy (55%) or dual therapy with metronidazole and vancomycin (45%). Patients were mostly older, females being treated for an initial episode of mild-to-moderate CDI. Common risk factors identified were age over 65 years (80%), use of antibiotics (83%) and proton pump inhibitors (PPI) (68%) within the previous 3 months. The use of a PPI in this study, a modifiable risk factor without a clear indication, was 35%. CONCLUSION: An area for antimicrobial stewardship intervention in CDI treatment at our hospital is prescribing the right antibiotic based on the CDI indication. In severe CDI, an emphasis should be on prescribing vancomycin monotherapy as the drug of choice. PPI use should be reassessed for tapering when appropriate.
format Online
Article
Text
id pubmed-7877108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78771082021-02-11 Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study Elbeddini, Ali Gerochi, Rachel J Pharm Policy Pract Research OBJECTIVES: Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of America 2010 C. difficile guideline. The primary objective of this study was to assess the treatment adherence to our algorithm; this was defined as therapy consisting of the appropriate antibiotic, dose, route, interval, and duration indicated based on the disease severity and episode within 24 h of diagnosis. Furthermore, our study also described the population and their risk factors for CDI at our hospital. METHODS: This was a single-centre, retrospective cohort chart review of CDI cases that were diagnosed at admission or during hospitalization from June 1st, 2017 to June 30th, 2018. Cases were identified by a positive stool test along with watery diarrhea or by colonoscopy. RESULTS: Sixty cases were included, of which adherence to our algorithm was 50%. Overall, severe CDI had the highest treatment non-adherence (83%), and the biggest contributing factor was prescribing the wrong antibiotic (72%). In severe CDI, which warrants vancomycin monotherapy, wrong antibiotic consisted of metronidazole monotherapy (55%) or dual therapy with metronidazole and vancomycin (45%). Patients were mostly older, females being treated for an initial episode of mild-to-moderate CDI. Common risk factors identified were age over 65 years (80%), use of antibiotics (83%) and proton pump inhibitors (PPI) (68%) within the previous 3 months. The use of a PPI in this study, a modifiable risk factor without a clear indication, was 35%. CONCLUSION: An area for antimicrobial stewardship intervention in CDI treatment at our hospital is prescribing the right antibiotic based on the CDI indication. In severe CDI, an emphasis should be on prescribing vancomycin monotherapy as the drug of choice. PPI use should be reassessed for tapering when appropriate. BioMed Central 2021-02-11 /pmc/articles/PMC7877108/ /pubmed/33568232 http://dx.doi.org/10.1186/s40545-020-00289-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Elbeddini, Ali
Gerochi, Rachel
Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title_full Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title_fullStr Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title_full_unstemmed Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title_short Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
title_sort treatment of clostridium difficile infection in community teaching hospital: a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877108/
https://www.ncbi.nlm.nih.gov/pubmed/33568232
http://dx.doi.org/10.1186/s40545-020-00289-1
work_keys_str_mv AT elbeddiniali treatmentofclostridiumdifficileinfectionincommunityteachinghospitalaretrospectivestudy
AT gerochirachel treatmentofclostridiumdifficileinfectionincommunityteachinghospitalaretrospectivestudy